Literature DB >> 16733650

Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.

R Konopke1, S Kersting, H Bergert, A Bloomenthal, J Gastmeier, H D Saeger, A Bunk.   

Abstract

BACKGROUND/AIMS: The advent of contrast-enhanced ultrasound (CEUS) has called into question the efficacy of standard ultrasonographic techniques. In this study, we evaluated B-mode and color-duplex imaging and CEUS in the detection of liver metastases, using intraoperative and histological findings as a reference.
MATERIALS AND METHODS: Before laparotomy, 108 patients suspected of having liver metastases were prospectively examined with B-mode and color-duplex imaging, followed by contrast-enhanced ultrasound (2.4 ml SonoVue). Patients with unresectable tumors (n=8) were excluded from the analysis. The sonographic diagnosis in the remaining 100 patients was compared to the intraoperative and histological findings. RESULTS/
FINDINGS: CEUS improved the sensitivity for detecting liver lesions from 56.3% (B-mode) to 83.8% (CEUS) (p=0.004). In particular, the contrast agent led to an improvement in ultrasonographic detection in the following cases: nodular metastases smaller than one centimeter; after adjuvant chemotherapy; for tumors near the surface of the liver; and for lesions situated around the ligamentum teres. INTERPRETATION/
CONCLUSIONS: CEUS provides significant improvement in the detection of liver metastases, and should therefore, be performed routinely in the surveillance of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733650     DOI: 10.1007/s00384-006-0134-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  40 in total

Review 1.  The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.

Authors:  E Leen
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Ultrasound imaging of focal liver lesions with a second-generation contrast agent.

Authors:  Riccardo Lencioni; Dania Cioni; Laura Crocetti; Francescamaria Donati; Chiara Franchini; Sabina Giusti; Carlo Bartolozzi
Journal:  Acad Radiol       Date:  2002-08       Impact factor: 3.173

3.  [Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents].

Authors:  T Bernatik; D Becker; D Neureiter; J Hänsler; M Frieser; S Schaber; E G Hahn; D Strobel
Journal:  Ultraschall Med       Date:  2003-06       Impact factor: 6.548

4.  Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease.

Authors:  D Bokor; J B Chambers; P J Rees; T G Mant; F Luzzani; A Spinazzi
Journal:  Invest Radiol       Date:  2001-02       Impact factor: 6.016

5.  [Malignant hepatobiliary tumors. Surgical requirements concerning preoperative diagnosis].

Authors:  F Köckerling; C Schug-Pass; H P Weskott; R Tatchen
Journal:  Zentralbl Chir       Date:  2000       Impact factor: 0.942

6.  Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.

Authors:  Alexandra von Herbay; Christoph Vogt; Reinhard Willers; Dieter Häussinger
Journal:  J Ultrasound Med       Date:  2004-12       Impact factor: 2.153

7.  Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.

Authors:  Thomas J Vogl; Wolfram Schwarz; Stefan Blume; Michael Pietsch; Kohkan Shamsi; Martina Franz; Hartmut Lobeck; Thomas Balzer; Kelly del Tredici; Peter Neuhaus; Roland Felix; Renate M Hammerstingl
Journal:  Eur Radiol       Date:  2002-09-10       Impact factor: 5.315

Review 8.  [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound].

Authors:  G Schuessler; A Ignee; T Hirche; C F Dietrich
Journal:  Z Gastroenterol       Date:  2003-12       Impact factor: 2.000

Review 9.  Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.

Authors:  R Adam
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

10.  [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].

Authors:  J Hohmann; J Skrok; R Puls; T Albrecht
Journal:  Rofo       Date:  2003-06
View more
  12 in total

Review 1.  Contrast-enhanced and targeted ultrasound.

Authors:  Michiel Postema; Odd Helge Gilja
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

Review 2.  Microbubble ultrasound contrast agents: an update.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

3.  The added value of contrast-enhanced ultrasound in patients with colorectal cancer undergoing preoperative evaluation with extensive gadobenate dimeglumine liver MRI.

Authors:  Nikolaos Kartalis; Torkel B Brismar; Laszlo Mihocsa; Bengt Isaksson; Nils Albiin
Journal:  Eur Radiol       Date:  2011-05-27       Impact factor: 5.315

Review 4.  [Diagnostic imaging of liver tumours. Current status].

Authors:  B Boozari; J Lotz; M Galanski; M Gebel
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

Review 5.  Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance.

Authors:  Vito Cantisani; Hektor Grazhdani; Cristina Fioravanti; Maria Rosignuolo; Fabrizio Calliada; Daniela Messineo; Maria Giulia Bernieri; Adriano Redler; Carlo Catalano; Ferdinando D'Ambrosio
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  [Detection and characterization of liver metastases].

Authors:  H-P Weskott
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

7.  Selection for hepatic resection of colorectal liver metastases: expert consensus statement.

Authors:  Reid B Adams; Thomas A Aloia; Evelyne Loyer; Timothy M Pawlik; Bachir Taouli; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

8.  Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: A review.

Authors:  Lars Peter Skovgaard Larsen
Journal:  World J Hepatol       Date:  2010-01-27

9.  Hepatic malignancies: Correlation between sonographic findings and pathological features.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-07-28

10.  Focused abdominal ultrasound in preoperative liver surgery staging: a prospective study.

Authors:  Marcela P Cohen; Paulo Herman; Rubens Chojniak; Miriam R B Poli; Paula N V Barbosa; Almir G V Bitencourt
Journal:  World J Surg Oncol       Date:  2013-06-14       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.